Weight loss and improvements in cardiometabolic outcomes with extended-release phentermine/topiramate treatment in overweight/obese subjects with type 2 diabetes

被引：0

作者：

Astrup, A. V. ^{[1
]}

Oppert, J. -M. ^{[2
]}

Peterson, C. A. ^{[3
]}

机构：

[1] Univ Copenhagen, LIFE, Dept Human Nutr, Frederiksberg, Denmark

[2] Univ Paris 06, Dept Nutr, Paris, France

[3] Vivus Inc, Mountain View, CA USA

来源：

DIABETOLOGIA | 2012年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

695

引用

页码：S284 / S285

页数：2

共 50 条

[31] Effect of gestational weight loss on perinatal outcomes in overweight and obese women with gestational and type 2 diabetes mellitus
Caughey, Aaron B.
Yee, Lynn M.
Cheng, Yvonne W.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S113 - S113
[32] Once-daily, controlled-release phentermine/topiramate (PHEN/TPM CR) results in significant weight loss and risk factor improvement in overweight/obese subjects over 56 weeks
Aronne, L. J.
Troupin, B.
Day, W. W.
DIABETES OBESITY & METABOLISM, 2010, 12 : 51 - 52
[33] Weight Loss (WL) With Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Correlates With Improvements in Liver Function in Overweight/Obese Adults With Elevated Alanine Aminotransferase (ALT)
Klein, Samuel
Najarian, Thomas
Troupin, Barbara
Day, Wesley W.
OBESITY, 2011, 19 : S177 - S177
[34] Extended-Release Exenatide (Bydureon) for Type 2 Diabetes
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1386): : 21 - 23
[35] Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Improves Hunger and Satiety, Leading to Weight Loss in Overweight/Obese Adults
Day, Wesley W.
Najarian, Thomas
Troupin, Barbara
Tam, Peter
Peterson, Craig
OBESITY, 2010, 18 : S154 - S154
[36] Effects of phentermine and topiramate extended-release (PHEN/TPM ER) on weight loss (WL) and glycaemic parameters by gender, race, and baseline body mass index (BMI)
Toplak, H.
Rossner, S.
Dvorak, R.
DIABETOLOGIA, 2013, 56 : S259 - S259
[37] AXOKINE® promotes weight loss in overweight and obese patients with type 2 diabetes mellitus
Glicklich, A
Bays, H
Russell, T
Weinstein, S
Hollander, P
OBESITY RESEARCH, 2003, 11 : A114 - A115
[38] Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
Mann, Katherine V.
Raskin, Philip
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 229 - 239
[39] A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults
Winslow, David H.
Bowden, Charles H.
DiDonato, Karen P.
McCullough, Pamela A.
SLEEP, 2012, 35 (11) : 1529 - 1539
[40] The effect of topiramate on weight loss in patients with type 2 diabetes
Moradi, Sedighe
Kerman, Scott Reza Jafarian
Mollabashi, Mina
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2013, 18 (04): : 297 - 302

← 1 2 3 4 5 →